CHICAGO—Flexan Medical Holdings L.L.C. said it will acquire Medron Inc., a medical device contract manufacturing services company based in Salt Lake City.
Medron offers a range of outsourcing services, including high volume manufacturing, customer private label capability, design engineering, product development and prototyping. It works with a variety of materials, primarily urethanes, silicones and thermoplastics.
The firm operates two facilities in the Salt Lake City area.
“We are excited to add Medron's vast array of capabilities to our custom medical molding services,” Jim Fitzgerald, president and CEO of Flexan Medical Holdings, said in a Dec. 5 news release. “Medron's reputation for providing high quality products from design to product launch and ongoing manufacturing support aligns well with our platform of providing long-term and short-term implantable silicone components. We are excited about the combination of our great brands, and our great people.”
Flexan said the acquisition supports the current trend of the medical device industry's strategic efforts to outsource with total solution providers who can consolidate critical offerings to address the needs of the global device market.
“We are thrilled to partner with Flexan,” Medron President Ron Wortley said in a statement. “The combined diversity of offerings along with strong technical management teams will bring significant value to our existing and new customers. Both organizations have similar cultures; each has a tremendous focus on innovation while delivering high quality products and the desire to help address serious clinical needs for our customers and ultimately the patient.”
Flexan is a global manufacturer of high-precision elastomer parts for a wide range of industry applications. It operates out of three manufacturing facilities with 500 employees and consists of two business units. Its Flexan unit focuses on custom molding while its FMI unit delivers clean room manufactured silicone rubber components for use in Class II disposable and Class III implantable medical devices.
The firm is owned by Linden Capital Partners, a Chicago-based a private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries.